WellTheory Secures $5M to Launch AI Tools to Transform Autoimmune Care

What You Should Know: 

– WellTheory, a whole-person care platform for autoimmune disease secures $5M in new funding and the successful rollout of its proprietary AI tools, Care Hub and Care Scribe, across its care operations. 

– New investors Samsung Next, Opal Ventures, and Up2 Fund joined the round, with continued support from existing investors Accel, OVO Fund, and BoxGroup.

– The new capital will fuel the company’s expansion into the employer and health plan markets and accelerate the development of its AI-powered care infrastructure for both providers and members.

Introducing Care Scribe and Care Hub: AI Tools Streamlining Care Delivery

At the heart of WellTheory’s AI advancement are two newly deployed proprietary tools:

• Care Scribe: This AI assistant now supports WellTheory’s Care Team by attending member sessions, transcribing conversations, and drafting follow-up notes and personalized Care Plans—all for provider review and customization. The tool has already demonstrated a significant impact, reducing provider preparation and documentation time by 65%, which enables a more efficient and focused care experience.
• Care Hub: Launched alongside Care Scribe, the Care Hub acts as a unified command center for WellTheory’s providers. It aggregates crucial member data, session history, and lab insights into one accessible location. Featuring dynamic workflows tailored to each session type, the Care Hub streamlines pre- and post-session tasks and enables automated compliance tracking, resulting in a smoother care journey for both providers and members.

WellTheory is positioning artificial intelligence as a cornerstone of its strategy to revolutionize care for complex autoimmune diseases. “AI is no longer a nice-to-have in care delivery — its essential infrastructure,” said Ellen Rudolph, CEO and Co-founder of WellTheory. “This new round of funding is allowing us to double down on our AI strategy, streamline the most time-consuming parts of care, and expand into new markets. We’re leading the charge in making whole-person, root-cause care more accessible, personalized, and effective — and bringing it to scale through our growing partnerships with employers and health plans.”